2m 2m 2m 2m 2m 2m 2m
Basilea Pharmaceu N (BPMUF)
OTC
$64.70-$4.82 (-7.41%)
Price as of Aug 03, 2026- N/AMarket Cap
- 4.46%1-Year Change
- BiotechnologyIndustry
Basilea Pharmaceu N (BPMUF)
$64.70-$4.82 (-7.41%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$64.70
$64.70
$64.70
1-Year Range
$59.29
$74.00
$64.70
Latest Close$64.70
Change
+$4.43 (+6.84%)
Volume1
Information as of 08/03/2026
Company Profile
BASILEA PHARM AG AKT SHS
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
BASILEA PHARM AG AKT SHS
Key Executives
- David Veitch
- Mark Jones
- Ursula Eberhardt
- Andreas Kumin
- Adesh Kaul
Current Ownership Distribution
- Other12.4M (99.98%)
- Mutual Funds2,272 (0.02%)
- Institutions0 (0.00%)
- Insiders0 (0.00%)